Virtually all of research at Jefferson—from Basic/ Discovery to Clinical/Translational to Applied—is grounded in or influenced by all three Scholarship lenses. This works because of the nature and range of professional and scholarly disciplines the University encompasses, and because of its determination to build transdisciplinary connections across the research spectrum. As you read this report you will note that each article includes the appropriate category or categories to identify where the subject falls in the epistemology.
Thomas Jefferson University is a unique institution, marked by dualities: simultaneously new and deeply experienced; steeped in tradition and heedless of traditional boundaries; professionally focused and committed to knowledge-creation.
Hear from Elda Grabocka, PhD, assistant professor of cancer biology and surgery, who is now using 3D cell culture models and mouse models to study stress granules’ specific role in drug resistance—and to investigate how oncogenic signaling and stress stimuli interact to promote pancreatic tumor development.
Read more about Grabocka's efforts in How to Re-Stress Pancreatic Cancer.
Soon after COVID-19 first emerged, Jefferson Vaccine Center (JVC) director and professor of microbiology and immunology Matthias Schnell, PhD, and his team created a killed-rabies vaccine that incorporates the spike portion of the SARS-COV-2 virus, which causes the disease—resulting in a COVID-19 vaccine candidate, CORAVAX™.
Thomas Jefferson University received a $70 million gift from Sidney and Caroline Kimmel to advance research at the University. The gift will support the new Caroline Kimmel Biomedical Research Building, which will be a home for big ideas and will provide Jefferson scientists with leading-edge technology and laboratories. The new facility will markedly expand Jefferson’s research capacity and create a “research corridor” that facilitates connections and collaborations among researchers across the University.
